Blog
- Beatson only UK site for pioneering prostate cancer trial
- Chief Scientist Office (CSO) - Supporting Patient and Public Involvement
- Clinical Research Practitioners register represents game-changing accreditation for vital part of research workforce
- ENRICH Scotland encourages the voices of care homes to speak louder in research
- First accredited Clinical Research Practitioner welcomed in Scotland
- Husband and wife support ENGAGE study
- Involving patients in cardiovascular research
- Much-needed funding provided to launch two Patient and Public Involvement (PPI) projects in Oral and Dental Health
- Organ and tissue transplantation research in Scotland
- Patient and public involvement in critical care
- Patient and public involvement in mental health
- Sustainable PPI in Co-designing Dundee Dental Hospital and Research School (DDH&RS)
- World Parkinson’s Day set to spark Scottish awareness of clinical research journey
NHS Research Scotland blogs cover elements of clinical research in Scotland in more depth, and feature writing from those directly involved in key studies taking place across the country.
If you are interested in featuring on the NRS blog, or have general queries, please contact communications@nrs.org.uk.
-
First accredited Clinical Research Practitioner welcomed in Scotland
26th July 2022
Scotland has its first accredited Clinical Research Practitioner (CRP), formally celebrating the valuable contribution of registration for health professionals and opening up further study opportunities.
Read full article
-
World Parkinson’s Day set to spark Scottish awareness of clinical research journey
11th April 2022
A new international symbol of awareness is set to inspire Scots on World Parkinson’s Day – in the shape of a simple spark.
Read full article
-
Husband and wife support ENGAGE study
15th September 2021
Taking part in a clinical trial was a family affair for husband and wife Phil and Helen Theaker.
Helen took part in the ENGAGE study – an international study to determine whether a new investigational medication, Aducanumab, can slow the progression of early Alzheimer’s disease.
Read full article